Standout Papers

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) 2022 2026 2023 2024200
  1. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) (2022)
    Xiaohan Xu, Kyle L. Poulsen et al. Signal Transduction and Targeted Therapy

Immediate Impact

61 standout
Sub-graph 1 of 22

Citing Papers

“The NET effect”: Neutrophil extracellular traps—a potential key component of the dysregulated host immune response in sepsis
2025 Standout
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier
2025 Standout
2 intermediate papers

Works of Xiaohan Xu being referenced

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
2022 Standout

Author Peers

Author Last Decade Papers Cites
Xiaohan Xu 71 90 51 198 127 40 671
Rui Fan 110 54 54 157 148 41 690
Neil Patel 111 54 38 144 128 65 641
Maria Kohl 82 44 108 131 74 30 689
Angela Chetrit 75 53 55 111 195 29 838
Nora Lee 109 88 62 138 156 44 720
Chiara Zusi 101 45 62 300 96 46 655
Raj Shah 219 53 72 124 51 39 668
Julia Chen 113 60 43 158 195 30 657
Lingyun Zhang 136 39 92 175 85 54 595
Shamsul Mohd Zain 70 56 26 349 157 46 824

All Works

Loading papers...

Rankless by CCL
2026